Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Hansen Scott G."" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł :
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
Autorzy :
Okoye AA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Vaidya M; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Fukazawa Y; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Park H; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Duell DM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Lum R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Ainslie E; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Legasse AW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Hesselgesser J; Gilead Sciences, Inc., Foster City, CA, USA.
Geleziunas R; Gilead Sciences, Inc., Foster City, CA, USA.
Li Y; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Fast R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Borate BR; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA. .
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2018 Sep; Vol. 24 (9), pp. 1430-1440. Date of Electronic Publication: 2018 Aug 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Retroviral Agents/*therapeutic use
Simian Acquired Immunodeficiency Syndrome/*drug therapy
Simian Acquired Immunodeficiency Syndrome/*virology
Simian Immunodeficiency Virus/*physiology
Adoptive Transfer ; Animals ; Anti-Retroviral Agents/pharmacology ; Drug Therapy, Combination ; Kinetics ; Macaca mulatta ; Necrosis ; Simian Immunodeficiency Virus/drug effects ; Vaccination ; Viral Vaccines/immunology ; Viremia/drug therapy ; Virus Replication
Czasopismo naukowe
Tytuł :
Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.
Autorzy :
Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Zak DE; Center for Infectious Disease Research, Seattle, Washington, USA.
Xu G; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Marshall EE; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Ainslie E; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Randall KT; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Selseth AN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Rundstrom P; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Herlache L; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Lewis MS; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Park H; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Planer SL; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Turner JM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Fischer M; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Armstrong C; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Zweig RC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Valvo J; Center for Infectious Disease Research, Seattle, Washington, USA.
Braun JM; Center for Infectious Disease Research, Seattle, Washington, USA.
Shankar S; Center for Infectious Disease Research, Seattle, Washington, USA.
Lu L; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
Sylwester AW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Legasse AW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Messerle M; Department of Virology, Hannover Medical School, Hannover, Germany.
Jarvis MA; School of Biomedical and Healthcare Sciences, University of Plymouth, Devon, UK.
Amon LM; Center for Infectious Disease Research, Seattle, Washington, USA.
Aderem A; Center for Infectious Disease Research, Seattle, Washington, USA.
Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
Laddy DJ; Aeras, Rockville, Maryland, USA.
Stone M; Aeras, Rockville, Maryland, USA.
Bonavia A; Aeras, Rockville, Maryland, USA.
Evans TG; Aeras, Rockville, Maryland, USA.
Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Edlefsen PT; Statistical Center for HIV-AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center (ONPRC), Oregon Health and Science University (OHSU), Beaverton, Oregon, USA.
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2018 Feb; Vol. 24 (2), pp. 130-143. Date of Electronic Publication: 2018 Jan 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Mycobacterium tuberculosis/*immunology
Tuberculosis/*immunology
Animals ; BCG Vaccine/immunology ; Cytomegalovirus/immunology ; Macaca mulatta/immunology
Czasopismo naukowe
Tytuł :
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.
Autorzy :
Hansen SG; Vaccine and Gene Therapy Institute, Department of Molecular Microbiology, and the Oregon National Primate Research Center, Oregon Health & Science University, 505 Northwest 185th Avenue, Beaverton, Oregon 97006, USA.
Vieville C
Whizin N
Coyne-Johnson L
Siess DC
Drummond DD
Legasse AW
Axthelm MK
Oswald K
Trubey CM
Piatak M Jr
Lifson JD
Nelson JA
Jarvis MA
Picker LJ
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2009 Mar; Vol. 15 (3), pp. 293-9. Date of Electronic Publication: 2009 Feb 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Mucosal*
Immunologic Memory*
CD4-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*immunology
Simian Immunodeficiency Virus/*immunology
Animals ; Humans ; Macaca mulatta ; Male ; Viral Vaccines/immunology
Czasopismo naukowe
Tytuł :
Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox.
Autorzy :
Hammarlund E; Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, USA.
Lewis MW
Carter SV
Amanna I
Hansen SG
Strelow LI
Wong SW
Yoshihara P
Hanifin JM
Slifka MK
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2005 Sep; Vol. 11 (9), pp. 1005-11. Date of Electronic Publication: 2005 Aug 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.; Technical Report
MeSH Terms :
Monkeypox/*immunology
Monkeypox/*prevention & control
Smallpox Vaccine/*immunology
Animals ; Antibodies, Viral ; Cross Reactions ; Disease Outbreaks ; Disease Reservoirs ; Humans ; Monkeypox/transmission ; Sciuridae/virology ; T-Lymphocytes/immunology ; Time Factors ; Wisconsin/epidemiology ; Zoonoses
Czasopismo naukowe
Tytuł :
Duration of antiviral immunity after smallpox vaccination.
Autorzy :
Hammarlund E; Oregon Health & Science University Vaccine and Gene Therapy Institute, 505 NW 185th Avenue, Beaverton, Oregon 97006, USA.
Lewis MW
Hansen SG
Strelow LI
Nelson JA
Sexton GJ
Hanifin JM
Slifka MK
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2003 Sep; Vol. 9 (9), pp. 1131-7. Date of Electronic Publication: 2003 Aug 17.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Immunologic Memory*
Smallpox Vaccine/*immunology
T-Lymphocytes/*immunology
Adult ; Aged ; Antibody Formation ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; Cross-Sectional Studies ; Female ; Half-Life ; Humans ; Immunization, Secondary ; Male ; Middle Aged ; Smallpox Vaccine/therapeutic use ; T-Lymphocytes/virology ; Time Factors ; Vaccinia virus/immunology
Czasopismo naukowe
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies